Cargando…
Long-Term Safety and Efficacy of Recombinant Human Parathyroid Hormone (1-84) in Adults With Chronic Hypoparathyroidism
CONTEXT: Chronic hypoparathyroidism is conventionally treated with oral calcium and active vitamin D to reach and maintain targeted serum calcium and phosphorus levels, but some patients remain inadequately controlled. OBJECTIVE: To assess long-term safety and efficacy of recombinant human parathyro...
Autores principales: | Watts, Nelson B, Bilezikian, John P, Bone, Henry G, Clarke, Bart L, Denham, Douglas, Levine, Michael A, Mannstadt, Michael, Peacock, Munro, Rothman, Jeffrey G, Vokes, Tamara J, Warren, Mark L, Yin, Shaoming, Sherry, Nicole, Shoback, Dolores M |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Oxford University Press
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10119703/ https://www.ncbi.nlm.nih.gov/pubmed/37091306 http://dx.doi.org/10.1210/jendso/bvad043 |
Ejemplares similares
-
OR30-1 Safety and Efficacy of Recombinant Human Parathyroid Hormone 1-84 for the Treatment of Adults with Chronic Hypoparathyroidism: Six-Year Results of the RACE Study
por: Bilezikian, John, et al.
Publicado: (2019) -
Safety and Efficacy of 5 Years of Treatment With Recombinant Human Parathyroid Hormone in Adults With Hypoparathyroidism
por: Mannstadt, Michael, et al.
Publicado: (2019) -
Effects of parathyroid hormone rhPTH(1–84) on phosphate homeostasis and vitamin D metabolism in hypoparathyroidism: REPLACE phase 3 study
por: Clarke, Bart L., et al.
Publicado: (2016) -
Recombinant Human Parathyroid Hormone Effect on Health-Related Quality of Life in Adults With Chronic Hypoparathyroidism
por: Vokes, Tamara J, et al.
Publicado: (2017) -
The PARADIGHM (physicians advancing disease knowledge in hypoparathyroidism) registry for patients with chronic hypoparathyroidism: study protocol and interim baseline patient characteristics
por: Gittoes, Neil, et al.
Publicado: (2021)